Neurogene Inc
NASDAQ:NGNE

Watchlist Manager
Neurogene Inc Logo
Neurogene Inc
NASDAQ:NGNE
Watchlist
Price: 20.41 USD 1.74%
Market Cap: 291.3m USD

DCF Value

This DCF valuation model was created by Alpha Spread and was last updated on Nov 24, 2025.

Estimated DCF Value of one NGNE stock is 19.24 USD. Compared to the current market price of 20.41 USD, the stock is Overvalued by 6%.

NGNE DCF Value
Base Case
19.24 USD
Overvaluation 6%
DCF Value
Price
Worst Case
Base Case
Best Case
DCF Value: 19.24 USD

Present Value Calculation

This block is the starting point of the DCF valuation process. It calculates the present value of a company's forecasted cash flows based on selected operating model. Adjust key parameters like discount rate and terminal growth, and alter inputs such as revenue growth and margins to see their impact on valuation.

DCF Model
Base Case Scenario

The present value of cash flows over the next 5 years amounts to 0 USD. The present value of the terminal value is 0 USD. The total present value equals 0 USD.
Forecast Period
Years
Discount Rate
%
Terminal Growth
%
Hide DCF Settings
Rotate your device to view
DCF Model
Year 1

forecasted

Year 2

forecasted

Year 3

forecasted

Year 4

forecasted

Year 5

forecasted

Terminal

forecasted

Operating Income
Revenue000000
Absolute Value
Growth
Operating Margin-27 515.10%-22 658.32%-17 798.65%-12 941.01%-8 083.37%-3 225.74%
Absolute Value
Operating Income000000
Net Operating Profit After Taxes
Taxes000000
Absolute Value
As % of Operating Income
NOPAT000000
Free Cash Flow to Firm
Net CapEx000000
Absolute Value
As % of Revenue
FCFF000000
Present Value
Discount Rate8.81%8.81%8.81%8.81%8.81%8.81%
Present Value000000
Save

DCF Value Calculation

This stage translates the present value into DCF value per share. For firm valuation models, it adjusts present value for debt and assets to derive equity value (skipped if using equity valuation model). Finally, this equity value is divided by the number of shares to determine the DCF value per share.

Present Value to DCF Value
Capital Structure

Present Value 0 USD
+ Cash & Equivalents 58.8m USD
+ Investments 215.7m USD
Firm Value 274.5m USD
- Debt 9k USD
Equity Value 274.5m USD
/ Shares Outstanding 14.3m
NGNE DCF Value 19.24 USD
Overvalued by 6%

Valuation Analysis

Sensitivity Analysis
DCF Value Sensitivity Analysis

Sensitivity Analysis assesses how changes in key factors like revenue growth, margin, and discount rate affect a stock's DCF value. By visualizing various scenarios, from significant downturns to optimistic growth, this tool helps you understand potential valuation shifts, aiding in risk assessment and strategic decision-making.

DCF Financials
Financials used in DCF Calculation

Revenue
0 0
Operating Income
0 0
FCFF
0 0

What is the DCF value of one NGNE stock?

Estimated DCF Value of one NGNE stock is 19.24 USD. Compared to the current market price of 20.41 USD, the stock is Overvalued by 6%.

The true DCF Value lies somewhere between the worst-case and best-case scenario values. This is because the future is not predetermined, and the stock's DCF Value is based almost entirely on the future of the company. Knowing the full range of possible stock DCF values gives a complete picture of the investment risks and opportunities.

How was the DCF Value calculated?

1. Present Value Calculation. Utilizing the DCF operating model, Neurogene Inc's future cash flows are projected and then discounted using a chosen discount rate to determine its Present Value, which is calculated at 0 USD.

2. DCF Value Calculation. The company's capital structure is employed to derive the total Equity Value from the previously calculated Present Value of the cash flow. This Equity Value, when divided by the total number of outstanding shares, yields the DCF Value of 19.24 USD per share.

Back to Top